[1]
Kamm MA,Mueller-Lissner S,Wald A,Richter E,Swallow R,Gessner U, Oral bisacodyl is effective and well-tolerated in patients with chronic constipation. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 2011 Jul;
[PubMed PMID: 21440672]
[2]
Kienzle-Horn S,Vix JM,Schuijt C,Peil H,Jordan CC,Kamm MA, Efficacy and safety of bisacodyl in the acute treatment of constipation: a double-blind, randomized, placebo-controlled study. Alimentary pharmacology
[PubMed PMID: 16669963]
Level 1 (high-level) evidence
[3]
Min YW,Ko EJ,Kim JH,Lee JY,Kim HC,Lee WY,Rhee PL, Increased Tone of the Human Colon Muscle by Bisacodyl In Vitro. Journal of neurogastroenterology and motility. 2018 Apr 30;
[PubMed PMID: 29605986]
[4]
Luthra P,Camilleri M,Burr NE,Quigley EMM,Black CJ,Ford AC, Efficacy of drugs in chronic idiopathic constipation: a systematic review and network meta-analysis. The lancet. Gastroenterology
[PubMed PMID: 31474542]
Level 1 (high-level) evidence
[5]
Kienzle-Horn S,Vix JM,Schuijt C,Peil H,Jordan CC,Kamm MA, Comparison of bisacodyl and sodium picosulphate in the treatment of chronic constipation. Current medical research and opinion. 2007 Apr;
[PubMed PMID: 17407625]
Level 3 (low-level) evidence
[6]
Manabe N,Cremonini F,Camilleri M,Sandborn WJ,Burton DD, Effects of bisacodyl on ascending colon emptying and overall colonic transit in healthy volunteers. Alimentary pharmacology
[PubMed PMID: 19678812]
[7]
An evidence-based approach to the management of chronic constipation in North America. The American journal of gastroenterology. 2005;
[PubMed PMID: 16008640]
[8]
Ewe K,Hölker B, [The effect of a diphenolic laxative (Bisacodyl) on water- and electrolyte transport in the human colon (author's transl)]. Klinische Wochenschrift. 1974 Sep 1;
[PubMed PMID: 4449188]
[9]
Noergaard M,Traerup Andersen J,Jimenez-Solem E,Bring Christensen M, Long term treatment with stimulant laxatives - clinical evidence for effectiveness and safety? Scandinavian journal of gastroenterology. 2019 Jan;
[PubMed PMID: 30700194]
[10]
Hervé S,Savoye G,Behbahani A,Leroi AM,Denis P,Ducrotté P, Results of 24-h manometric recording of colonic motor activity with endoluminal instillation of bisacodyl in patients with severe chronic slow transit constipation. Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society. 2004 Aug;
[PubMed PMID: 15305994]
[11]
Ewe K, Effect of bisacodyl on intestinal electrolyte and water net transport and transit. Perfusion studies in men. Digestion. 1987;
[PubMed PMID: 3678638]
[13]
Ikarashi N,Baba K,Ushiki T,Kon R,Mimura A,Toda T,Ishii M,Ochiai W,Sugiyama K, The laxative effect of bisacodyl is attributable to decreased aquaporin-3 expression in the colon induced by increased PGE2 secretion from macrophages. American journal of physiology. Gastrointestinal and liver physiology. 2011 Nov;
[PubMed PMID: 21868635]
[14]
Bassotti G,Chiarioni G,Germani U,Battaglia E,Vantini I,Morelli A, Endoluminal instillation of bisacodyl in patients with severe (slow transit type) constipation is useful to test residual colonic propulsive activity. Digestion. 1999 Jan-Feb;
[PubMed PMID: 9892801]
[16]
Wald A, Is chronic use of stimulant laxatives harmful to the colon? Journal of clinical gastroenterology. 2003 May-Jun;
[PubMed PMID: 12702977]
[17]
Joo JS,Ehrenpreis ED,Gonzalez L,Kaye M,Breno S,Wexner SD,Zaitman D,Secrest K, Alterations in colonic anatomy induced by chronic stimulant laxatives: the cathartic colon revisited. Journal of clinical gastroenterology. 1998 Jun;
[PubMed PMID: 9649012]
[18]
Portalatin M,Winstead N, Medical management of constipation. Clinics in colon and rectal surgery. 2012 Mar;
[PubMed PMID: 23449608]
[19]
Soufi-Afshar I,Moghadamnia A,Bijani A,Kazemi S,Shokri-Shirvani J, Comparison of pyridostigmine and bisacodyl in the treatment of refractory chronic constipation. Caspian journal of internal medicine. 2016 Winter
[PubMed PMID: 26958328]
[20]
Alikiaii B,Majedi MA,Hashemi ST,Kiani M, Comparing the Efficacy of Two Drugs Senalin and Bisacodyl in Treatment of Constipation in Intensive Care Units' Patients. Advanced biomedical research. 2019
[PubMed PMID: 30993087]
[21]
Ajani S,Hurt RT,Teeters DA,Bellmore LR, Ischaemic colitis associated with oral contraceptive and bisacodyl use. BMJ case reports. 2012 Jul 25
[PubMed PMID: 22843752]
Level 3 (low-level) evidence
[22]
Wang DJ,Chu KM,Chen JD,Tarn YH,Su DJ, [Drug interaction between digoxin and bisacodyl]. Journal of the Formosan Medical Association = Taiwan yi zhi. 1990 Oct
[PubMed PMID: 1981783]
[23]
Wickham RJ, Managing Constipation in Adults With Cancer. Journal of the advanced practitioner in oncology. 2017 Mar;
[PubMed PMID: 29900023]
[24]
Kudo K,Miyazaki C,Kadoya R,Imamura T,Jitsufuchi N,Ikeda N, Laxative poisoning: toxicological analysis of bisacodyl and its metabolite in urine, serum, and stool. Journal of analytical toxicology. 1998 Jul-Aug;
[PubMed PMID: 9681329]
[25]
Wu WJ,Huang CH,Chiang CP,Huang CN,Wang CN, Urolithiasis related to laxative abuse. Journal of the Formosan Medical Association = Taiwan yi zhi. 1993 Nov;
[PubMed PMID: 7910057]
[27]
Roerig JL,Steffen KJ,Mitchell JE,Zunker C, Laxative abuse: epidemiology, diagnosis and management. Drugs. 2010 Aug 20
[PubMed PMID: 20687617]